Country Profile

Botswana

Botswana is a growing market for Indian pharmaceuticals — $14.2M in FY 2025–26. Medicines accounts for 93% of shipments, with vaccines contributing $915K.

🇧🇼 $14.2M · 0.9× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$14.2M
Exports FY2025–26 DGCIS
0.9×
Growth FY2015→2026
93%
Medicines Share
5
Product Categories Supplied
12
Years of Trade Data
Botswana is a growing market for Indian pharmaceuticals — $14.2M in FY 2025–26. Medicines accounts for 93% of shipments, with vaccines contributing $915K.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $13.1M (92.6%) Vaccines $915K (6.4%) Surgical & Hospital Supplies $97K (0.7%) Medicine Ingredients $20K (0.1%) Traditional & Herbal $15K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Botswana in the RBI overseas direct investment dataset (2011–2026).